Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study is a research paper published in Transplantation and Cellular Therapy (2024). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Anhui Provincial Department of Education
Grant: 2023AH010079
National Natural Science Foundation of China
Grant: U23A20453
National Natural Science Foundation of China
Grant: 82170209
National Natural Science Foundation of China
Grant: 82270223
University of Science and Technology of China
Grant: 2024/RE/81
Anhui Provincial Key Research and Development Plan
Grant: 2022e07020015
Anhui Provincial Natural Science Foundation
Grant: 2308085J09
Shanxi Medical University
FWCI
0.87
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals